chr11-71473279-AAACCGTACCCTTCGG-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4PP3
The NM_018161.5(NADSYN1):c.463_477del(p.Thr155_Gly159del) variant causes a inframe deletion, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: not found (cov: 34)
Consequence
NADSYN1
NM_018161.5 inframe_deletion, splice_region
NM_018161.5 inframe_deletion, splice_region
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.72
Genes affected
NADSYN1 (HGNC:29832): (NAD synthetase 1) Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).[supplied by OMIM, Apr 2004]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_018161.5.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NADSYN1 | NM_018161.5 | c.463_477del | p.Thr155_Gly159del | inframe_deletion, splice_region_variant | 7/21 | ENST00000319023.7 | NP_060631.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NADSYN1 | ENST00000319023.7 | c.463_477del | p.Thr155_Gly159del | inframe_deletion, splice_region_variant | 7/21 | 1 | NM_018161.5 | ENSP00000326424 | P1 | |
NADSYN1 | ENST00000528509.5 | c.463_477del | p.Thr155_Gly159del | inframe_deletion, splice_region_variant, NMD_transcript_variant | 7/10 | 1 | ENSP00000433472 | |||
NADSYN1 | ENST00000525200.5 | c.363_377del | p.Thr122_Gly126del | inframe_deletion, splice_region_variant, NMD_transcript_variant | 6/21 | 2 | ENSP00000432129 | |||
NADSYN1 | ENST00000529120.5 | splice_region_variant, 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 5 | ENSP00000437220 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NADSYN1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The NADSYN1 c.463_477del15 variant is predicted to result in an in-frame deletion (p.Thr155_Gly159del). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.